These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24073401)
81. Synthesis and in vitro and in vivo biological evaluation of substituted nitroquinoxalin-2-ones and 2,3-diones as novel trichomonacidal agents. Ibáñez-Escribano A; Reviriego F; Nogal-Ruiz JJ; Meneses-Marcel A; Gómez-Barrio A; Escario JA; Arán VJ Eur J Med Chem; 2015 Apr; 94():276-83. PubMed ID: 25771033 [TBL] [Abstract][Full Text] [Related]
82. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. Kumar A; Roy S; Tripathi S; Sharma A J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809 [TBL] [Abstract][Full Text] [Related]
83. Trichomoniasis: mechanism of infection, recurrences and reinfections in man. Bedoya JM Gynakol Rundsch; 1983; 23 Suppl 2():10-5. PubMed ID: 6688792 [No Abstract] [Full Text] [Related]
84. Nitrimidazine in the treatment of trichomoniasis. Moffett M; McGill MI; Schofield CB; Masterton G Br J Vener Dis; 1971 Jun; 47(3):173-6. PubMed ID: 5090741 [No Abstract] [Full Text] [Related]
85. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies. Ramamoorthy D; Turos E; Guida WC J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389 [TBL] [Abstract][Full Text] [Related]
86. Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study. Anusuya S; Velmurugan D; Gromiha MM J Biomol Struct Dyn; 2016 Jul; 34(7):1512-32. PubMed ID: 26262439 [TBL] [Abstract][Full Text] [Related]
87. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation. Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984 [TBL] [Abstract][Full Text] [Related]
88. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519 [TBL] [Abstract][Full Text] [Related]
89. [Clinical use of a new trichomonacidal drug by systemic administration]. Oppo GT Minerva Ginecol; 1978 Mar; 30(3):221. PubMed ID: 662201 [No Abstract] [Full Text] [Related]
90. Trichomonas vaginalis orchitis with associated severe oligoasthenoteratospermia and hypogonadism. Lloyd G; Case JR; De Frias D; Brannigan RE J Urol; 2003 Sep; 170(3):924. PubMed ID: 12913736 [No Abstract] [Full Text] [Related]
91. Synthesis and biological activity of new 2-nitroimidazole derivatives. Cavalleri B; Volpe G; Arioli V; Pizzocheri F; Diena A J Med Chem; 1978 Aug; 21(8):781-4. PubMed ID: 211235 [TBL] [Abstract][Full Text] [Related]
92. Mind the gap: bridging the divide between clinical and molecular studies of the trichomonads. Lyons EJ; Carlton JM Trends Parasitol; 2004 May; 20(5):204-7. PubMed ID: 15105016 [No Abstract] [Full Text] [Related]
93. Recent developments in anti-Trichomonas research: An update review. Bala V; Chhonker YS Eur J Med Chem; 2018 Jan; 143():232-243. PubMed ID: 29175675 [TBL] [Abstract][Full Text] [Related]
95. Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery. Zafar A; Ahmad S; Rizvi A; Ahmad M PLoS One; 2015; 10(5):e0123996. PubMed ID: 25933436 [TBL] [Abstract][Full Text] [Related]
96. Dataset on double mutation in PGIP of Rashmi M; Murmu S; Nagrale DT; Singh MK; Behera SK; Shankar R; Ranjan R; Jha GK; Chaurasia A; Kumar S Data Brief; 2024 Jun; 54():110518. PubMed ID: 38827253 [TBL] [Abstract][Full Text] [Related]
97. Discovery and Characterization of the Antimetabolite Action of Thioacetamide-Linked 1,2,3-Triazoles as Disruptors of Cysteine Biosynthesis in Gram-Negative Bacteria. Wallace MJ; Dharuman S; Fernando DM; Reeve SM; Gee CT; Yao J; Griffith EC; Phelps GA; Wright WC; Elmore JM; Lee RB; Chen T; Lee RE ACS Infect Dis; 2020 Mar; 6(3):467-478. PubMed ID: 31887254 [TBL] [Abstract][Full Text] [Related]
98. Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites. Mori M; Jeelani G; Masuda Y; Sakai K; Tsukui K; Waluyo D; Tarwadi ; Watanabe Y; Nonaka K; Matsumoto A; Ōmura S; Nozaki T; Shiomi K Front Microbiol; 2015; 6():962. PubMed ID: 26441896 [TBL] [Abstract][Full Text] [Related]
99. Molecular dynamic simulation and inhibitor prediction of cysteine synthase structured model as a potential drug target for trichomoniasis. Singh S; Sablok G; Farmer R; Singh AK; Gautam B; Kumar S Biomed Res Int; 2013; 2013():390920. PubMed ID: 24073401 [TBL] [Abstract][Full Text] [Related]